Literature DB >> 7892357

A longitudinal study of the neuropsychiatric consequences of HIV-1 infection in gay men. II. Psychological and health status at baseline and at 12-month follow-up.

K Pugh1, M Riccio, D Jadresic, A P Burgess, T Baldeweg, J Catalan, E Lovett, D A Hawkins, J Gruzelier, C Thompson.   

Abstract

The aim of this study was to determine whether HIV infection is associated with increased psychosocial distress in the asymptomatic and early symptomatic stages of disease and to determine the factors associated with reporting health symptoms. Subjects included 61 gay men (41 HIV--, 20 HIV+) who were assessed at the time of requesting their first HIV test and again 12 months later. Measures included a detailed standardized psychiatric interview (Present State Examination, PSE), a range of psychosocial self-report measures and a physical symptom checklist. There were no differences between the HIV+ and HIV-- groups in terms of self-reported symptoms. Multiple regression analysis showed that the symptom reporting was not associated with clinical or immunological markers of disease progression but was associated with measures of psychosocial distress. Although both groups showed elevated levels of psychosocial distress at the time of HIV testing, there were no differences between serostatus groups at follow-up. Multiple regression analysis indicated that the best predictors of PSE scores at follow-up were baseline PSE score and a history of psychiatric illness. Early HIV disease is not associated with increased psychosocial distress and symptom reporting is more closely related to psychological measures than to clinical or immunological markers of disease.

Entities:  

Mesh:

Year:  1994        PMID: 7892357     DOI: 10.1017/s0033291700028981

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  7 in total

Review 1.  Drug treatment of depression in HIV-positive patients : safety considerations.

Authors:  Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

3.  The role of illness, resources, appraisal, and coping strategies in adjustment to HIV/AIDS: the direct and buffering effects.

Authors:  K I Pakenham; M Rinaldis
Journal:  J Behav Med       Date:  2001-06

4.  Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex.

Authors:  S Brooke; R Chan; S Howard; R Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

5.  Patterns of responses on health-related quality of life questionnaires among patients with HIV/AIDS.

Authors:  Ian Kudel; Stacey L Farber; Joseph M Mrus; Anthony C Leonard; Susan N Sherman; Joel Tsevat
Journal:  J Gen Intern Med       Date:  2006-12       Impact factor: 5.128

6.  Two-year prospective study of major depressive disorder in HIV-infected men.

Authors:  J Hampton Atkinson; Robert K Heaton; Thomas L Patterson; Tanya Wolfson; Reena Deutsch; Stephen J Brown; J Summers; A Sciolla; R Gutierrez; Ronald J Ellis; Ian Abramson; John R Hesselink; J Allen McCutchan; Igor Grant
Journal:  J Affect Disord       Date:  2007-11-28       Impact factor: 4.839

7.  Contribution of substance abuse and HIV infection to psychiatric distress in an inner-city African-American population.

Authors:  C U Nnadi; W Better; K Tate; R I Herning; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2002-05       Impact factor: 1.798

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.